Rotarix Liquid Oral Vaccine 1,5 ml Clear, colourless liquid, free of visible particles
PDF Leaflet Revision Date: 13 February 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention of gastro-enteritis caused by Rotavirus in infants.
Dosage (summary)
Two doses; first dose from 6 weeks, second dose at least 4 weeks later, to be completed by 24 weeks.
Special Populations
- Preterm infants
- HIV-infected infants
Pregnancy & Breastfeeding
Not intended for adults; no data on use during pregnancy or lactation.
Key Drug Interactions
- Concomitant administration with routine vaccines is safe
Contraindications
- Hypersensitivity to vaccine components
- Immunodeficiency
- History of intussusception
Common side effects
- Diarrhoea
- Irritability
- Abdominal pain
Counselling Points
- Complete the vaccination course
- Monitor for symptoms of intussusception
- Maintain hygiene after vaccination
Serious warnings
- Risk of intussusception
- Do not inject
Important Disclaimer
The Rotarix Liquid Oral Vaccine 1,5 ml Clear, colourless liquid, free of visible particles professional information leaflet below is the property of Glaxosmithkline South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
